The intersection of AI and machine learning with in vitro diagnostics (IVD) is transforming how diseases are detected, interpreted, and managed. What once required laborious lab workflows and human interpretation is now being augmented — and in many cases enhanced — by intelligent systems capable of learning, predicting, and optimizing diagnostic processes.
A Study by Grand View...
According to a newly published market research report by 24LifeSciences, global immunodiagnostics market was valued at USD 11,660 million in 2024 and is projected to reach USD 17,680 million by 2031, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 20252031.
Immunodiagnostics involves advanced testing...
In Vitro Diagnostics Contract Manufacturing has emerged as a critical backbone of modern healthcare innovation. As diagnostic technologies become more advanced and demand for rapid, accurate testing grows, healthcare companies are increasingly turning to specialized partners to handle complex manufacturing processes. This shift is not only improving efficiency but also accelerating the...
The Evolving Landscape of In Vitro Diagnostics
In recent years, in vitro diagnostics (IVD) has emerged as a cornerstone of modern healthcare, enabling clinicians to make faster, more accurate decisions through advanced diagnostic tests. From routine blood panels to complex molecular assays, laboratory diagnostics continue to expand in capability, driven by technological innovation and the...